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A B S T R A C T
Purpose: Neuroimaging is critical in deciding candidacy for epilepsy surgery. Currently imaging is
primarily assessed qualitatively, which may affect patient selection and outcomes.
Method: The epilepsy surgery database at MGH was reviewed for temporal lobectomy patients from the
last 10 years. Radiology reports for MRI and FDG-PET were compared to the epilepsy conference
consensus. First, speciﬁc ﬁndings of ipsi/contra hippocampal atrophy and T2 signal changes were
directly compared. Next the overall impression of presence of hippocampal sclerosis (HS) for MRI and
temporal hypometabolism for PET was used for sensitivity/speciﬁcity analysis. To assess predictive
power of imaging ﬁndings logistic regression was used.
Results: 104 subjects were identiﬁed. 70% of subjects were ILAE class I at 1-year. Radiology reports and
the conference consensus differed in 31% of FDG-PET studies and 41% of MRIs. For PET most
disagreement (50%) stemmed for discrepancy regarding contralateral temporal hypometabolism. For
MRI discrepancy in ipsilateral hippocampal atrophy/T2 signal accounted for 59% of disagreements.
When overall impression of the image was used the overall reliability between groups was high with
only MRI sensitivity to detect HS (0.75 radiology, 0.91 conference, p = 0.02) was signiﬁcantly different
between groups. On logistic regression MRI was a signiﬁcant predictor of HS, but still 36% of patients
with normal MRI as read by both groups had HS on pathology.
Conclusion: Despite some difference in speciﬁc radiologic ﬁndings, overall accuracy for MRI and PET is
similar in clinical practice between radiology and conference; nonetheless there are still cases of
hippocampal pathology not detected by standard imaging methods.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Temporal lobectomy is an effective treatment for medication
refractory temporal lobe epilepsy [9], but not all patients beneﬁt
equally. 10–40% of patients still have seizures post-operatively
[7,9]. While there are many reasons for surgical failures one
potential etiology with minimal investigation is the variability in
the interpretation of pre-operative imaging. Pre-surgical neuroim-
aging typically consists of MRI and 18F-Fluorodeoxyglucose (FDG)-
positron emission tomography (PET). The primary ﬁndings of
interests are the presence of T2 hyper-intensity and atrophy of the
hippocampus for MRI and temporal lobe hypometabolism for FDG-
PET [4]. Typically images are interpreted by neuro-radiologists and
then again by clinicians at an epilepsy surgical conference.
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interpret images. This methodology is by its nature subjective and
may be susceptible to issues of intra/inter-rater reliability. It is
unclear how this subjectivity may affect patient selection and
thereby surgical outcomes. This study assesses this variability in a
real-world clinical setting by comparing radiology reports to
epilepsy surgery conference notes. Data is then compared to
endpoints including seizure-free rates and presence of hippocam-
pal sclerosis on pathology.
2. Methods
The epilepsy surgery database at Massachusetts General
Hospital (MGH) was queried for patients that underwent temporal
lobectomy from 2003 to 2013. The study was conducted with
approval from the IRB. Inclusion criteria were, age >18, epilepsy
surgery conference presentation, and MRI and PET imaging at
MGH. Patients were excluded if they had a structural lesion of the
temporal lobe other than hippocampal sclerosis (HS), based on theserved.
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anterior temporal lobectomy. Imaging reports and conference
notes were assessed for ipsilateral and contralateral ﬁndings
including MRI ﬁndings of hippocampal atrophy and increased
hippocampal T2 signal, and FDG-PET ﬁndings of temporal lobe
hypometabolism. The epilepsy surgery conference was attended
by a neuroradiologist that aided in the interpretation of the study.
Only infrequently was this the same neuroradiologist that read the
clinical study. Imaging reports were categorized on a scale of 0 for
no ﬁndings suggestive of HS or temporal lobe hypometabolism, 1
for mild, possible, or subtle ﬁndings, and 2 for deﬁnite or probable
ﬁndings. For each subject the interpretations were compared for
change in the degree of certainty of ﬁndings and for new ﬁndings.
The following ﬁndings were assessed: change in ipsilateral and
contralateral T2 signal in the hippocampus, ipsilateral and
contralateral hippocampal atrophy, and in the case of PET
ipsilateral contralateral hypometabolism. For example if a
radiology report did not ﬁnd hippocampal atrophy and the
conference felt that is might be present that would be considered
a new ﬁnding and the interpretation was different. If the
conference felt there was deﬁnite increased hippocampal T2
signal and the radiology found possible increased T2 signal this
would be considered a difference in the strength of the ﬁnding. For
purposes of sensitivity/speciﬁcity analysis only ipsilateral ﬁndings
were considered and any ﬁnding, independent of the strength of
that ﬁnding, suggestive of ipsilateral hippocampal sclerosis or in
the case of PET ipsilateral hypometabolism was considered
positive. These binominal data were used to develop 2X2
contingency tables to assess sensitivity, speciﬁcity, positive
predictive value (PPV), negative predictive value (NPV), and
accuracy. Proportions were compared using Z-test comparisons
of proportions. Logistic regression was used to assess the
relationship between interpretation and the categorical outcomes
variables of HS on pathology and seizure freedom at 1-year post-
operation (ILAE class 1) [1]. Univariate and multivariate logistic
regression using a Chi-square statistic with a p < 0.05 was used to
determine signiﬁcance of predictor variables and a McFadden
pseudo-R2was used to assess goodness of ﬁt [5]. Statistical analysis
was done with the Matlab Statistics Toolbox Release 2013b
(MathWorks, Natick, MA).
The MR images are acquired with the MGH epilepsy protocol
primarily acquired on a 3 T or 1.5 T Siemens MRI with sequences
including high-resolution MPRAGE, coronal/axial FLAIR, T2 TSE
through hippocampi, SPACE T2 FLAIR, SPACE T2, and axial SWI. PET
imaging was performed approximately 45 min following adminis-
tration of 5.0-mCi of [18F] ﬂuorodeoxyglucose. Patients were
screened with ﬁnger stick glucose prior to FDG administration.
Imaging was performed on an ECAT HR scanner (CTI-Seimens,
Knoxville, Tennessee) and acquired in 3D mode with attenuation
correction from a transmission scan or with CT. A maximum
likelihood reconstruction method was used.
3. Results
104 subjects were eligible for inclusion in the study. There was
incomplete data from 40 subjects. These subjects lacked speciﬁc
mention of conference interpretation of either PET or MR data.
Mean age at surgery was 40 years. Mean follow-up duration was 36
months. 70% of the patients were ILAE class I at 1-year. Of the 104
cases, 71 (68%) of them had HS on pathology, while the others had
non-speciﬁc gliosis or normal pathology.
76 patients had FDG-PET reports from radiology and documen-
tation of discussion at conference. In 31% (24 patients), 95%
conﬁdence interval (CI): 21–41%, there was a difference in ﬁndings.
In 12 patients (50% of cases with difference) the reason for
difference was the conference disagreed with the ﬁnding ofcontralateral PET hypometabolism found in radiology reports. In 6
patients (25% of cases with difference) the conference found
ipsilateral hypometabolism not found by radiology. In 1 patient
(4%) radiology felt there was ipsilateral hypometabolism and the
conference did not agree. In 6 patients (25%) radiology felt there
was possible ipsilateral hypometabolism, but conference felt this
ﬁnding was deﬁnite. Note that one patient had two disagreements
with both a change in the strength of the ipsilateral hypometa-
bolism and a disagreement regarding presence of contralateral
hypometabolism.
With MRI 82 patients had both a report from radiology and
documentation from conference. 34 patients (41%, 95%-CI 31–53%)
had a difference in interpretation of MRI. 24 patients had new
ﬁndings described by one group and not the other. 20 patients
were felt to have ipsilateral hippocampal changes by conference
and not by radiology with 8 having increased T2 signal, 5 having
hippocampal atrophy, and 7 having both signal change and
atrophy. Two patients were felt to have hippocampal atrophy by
radiology and not by conference. One patient was felt to have
contralateral hippocampal atrophy by radiology, but not by
conference. One patient was felt to have abnormal ipsilateral
hippocampal T2 signal by radiology but not by conference and
hippocampal atrophy by conference but not by radiology. The
remaining 10 patients had a disagreement regarding the strength
of the ﬁndings. Conference found deﬁnite ﬁndings where radiology
found only possible or questionable ﬁndings. All of these were in
regard to ipsilateral hippocampal changes with 4 related to T2
signal change, 3 to hippocampal atrophy, and 3 involving both
signal change and atrophy.
For the next analysis the interpretations were compared to
surgical outcomes and surgical pathology. For MRI the presence of
HS on surgical pathology was used as a reference standard. MRIs
read as normal by radiology had HS on pathology 50% of the time,
while that number was 36% for conference. For MRIs read as having
possibly abnormal mesial temporal structures, HS was found on
pathology 62% for radiology and 40% for epilepsy conference. For
MRIs read as probably or deﬁnitely abnormal the percentages were
83% for radiology and 88% for epilepsy.
For FDG-PET, complete seizure-freedom at one year (ILAE class
1) was used as the reference standard. 17% of patients with a PET
read as normal by radiology were a seizure-free, while 0% of
patients with a normal PET as read by conference were a seizure
free. For possibly abnormal PET imaging the numbers were 75% for
radiology and 57% of conference. For patients whose PETs were
read as deﬁnitely abnormal 72% were seizure-free for both the
radiology and conference.
While there were many apparent differences between inter-
pretations regarding which abnormalities (atrophy versus signal
change) were present and to what extent the abnormalities were
present, ultimately the critical factor is whether the medial
temporal structures were felt to be abnormal or not. So for the
sensitivity/speciﬁcity analysis any possible or probable abnormal-
ity was considered a positive test. Of the patients with a normal MR
study as read by radiology 17/34 (50%) had HS, and 53/69 (77.7%)
read as abnormal had HS. For conference interpretation of MR 5/14
(35.7%) read as normal had HS while 51/69 (74.0%) read as
abnormal had HS. For the radiology interpretation of PET, 1/6
(16.7%) read as normal had ILAE class 1 at 1-year, while 53/73
(72.6%) read as abnormal were ILAE class 1 at 1-year. For
conference interpretation of PET 0/3 (0%) read as normal were
ILAE class 1 at 1-year and 43/61 (70.5%) of abnormal studies were
ILAE class 1 at 1-year. Using this methodology the sensitivity,
speciﬁcity, NPV, PPV, and overall accuracy were calculated (Fig. 1).
The sensitivity of MRI to detect hippocampal sclerosis was the only
measure that differed signiﬁcantly between epilepsy conference
and radiology interpretations (0.91 0.76 p = 0.02).
Fig. 1. Sensitivity, speciﬁcity, positive predictive value (PPV), predictive value
(NPV), and accuracy of FDG-PET (b) to predict seizure freedom at 1-year post-
surgery, and for MRI (a) to predict hippocampal sclerosis on pathology. * shows a
statistically signiﬁcant difference at p < 0.02.
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and surgical outcomes a logistic regression was performed.
Univariate and multivariate logistic regression results are shown
in Table 1. PET was a signiﬁcant predictor of outcome for both
radiology and conference. MRI was signiﬁcant predictor ofTable 1
Univariate logostic regression: outcome.
Rad Conf
p R2 P R2
PET Ipsi 0.02 0.16 0.02 0.29
PET Contra* 0.03 0.15 0.62 0.24
MRI Ipsi 0.07 0.03 0.03 0.22
Multivariate logistic regression: outcome
PET ipsi 0.03 0.17 0.08 0.32
MR ipsi 0.17 0.15
Univariate logostic regression: hippocampal sclerosis
PET Ipsi 0.02 0.15 0.02 0.28
MRI Ipsi <0.01 0.12 <0.01 0.34
Multivariate logistic regression: hippocampal sclerosis
PET ipsi 0.08 0.23 0.36 0.39
MR ipsi <0.01 <0.01
PET Ipsi: ipsilateral FDG-PET HM; PET Contra is contralateral FDG-PET HM; MRI ipsi
is ispilateral hippocampal atrophy and signal change; Rad is radiology; Conf is
conference report, * absence of contralateral hypometabolism; R2 is the log-
likelihood.
Bold values represent p values less than 0.05.hippocampal sclerosis for both. MRI was a signiﬁcant predictor
of outcomes only for conference at p = 0.03 (radiology p = 0.07). On
multivariate regression PET remained signiﬁcant adjusted for MRI
only for radiology. MRI remained a signiﬁcant predictor of
hippocampal sclerosis adjusted for PET for both groups. Conference
results in general had a higher pseudo-R2 meaning they explained
more of the variation in outcomes.
4. Discussion
Comparing epilepsy surgery conference reports and radiology
reports resulted in differences in 31% of FDG-PETs and 41% of MRIs,
with most variability coming from differences in opinion about
contralateral hypometabolism on PET and subtle hippocampal
changes on MRI. When these data were combined in sensitivity/
speciﬁcity analysis using surgical outcomes and pathology, overall
accuracy for detecting ‘‘any abnormality’’ was comparable
between the two groups. Overall there was a trend for the
radiology reports to be more speciﬁc and the conference to be more
sensitive, but this resulted in only one statistically signiﬁcant
ﬁnding of the conference having a greater sensitivity of MRI to
detect HS. The trade-off of improved sensitivity with conference
was countered by a decreased speciﬁcity resulting in an overall a
similar accuracy for both groups. With logistic regression there
was a consistent yet modest difference between the radiology and
conference in the goodness of ﬁt parameter (McFadden’s pseudo-
R2). These data taken together suggest, but do not prove, a modest
increase in predictive strength for the conference that likely stems
from the inﬂuence of clinical and electrographic data.
Using a patient population that all underwent surgery allows
for a robust gold-standard because surgical specimens are
available to compare to pre-operative imaging. But it also limits
the number of true-negatives depressing the speciﬁcity. Nonethe-
less these numbers may be more reﬂective of actual epilepsy
surgery clinical practice than prior studies. The results of prior
studies assessing the visual accuracy of MR in TLE have varied, with
some suggesting a high sensitivity and speciﬁcity for hippocampal
sclerosis (sensitivity = 0.93, speciﬁcity 0.83) with fairly high inter-
rater reliability a kappa 0.70 (87% agreement) (hippocampal signal
change) and of 0.56 (74% agreement) (hippocampal atrophy) for
visual assessment of mesial temporal lobe structures in temporal
lobe epilepsy [3]. Others found substantially lower sensitivity
between 44 and 87% [2].
The current study had a slightly different methodology by using
actual clinical interpretations of images, as opposed to interpreta-
tions performed in a research setting. The intent was to determine
whether enough uncertainty existed to justify the use of
quantitative techniques for measuring hippocampal volume and
PET hypometabolism. The ﬁndings from this study suggest that
there may be only minor differences in the visual assessment of
imaging, but there is still a large amount of variability in outcomes
not accounted for by the speciﬁc imaging ﬁndings examined in this
study. This is reﬂected in the modest pseudo-R2 scores and by the
36% of patients with MRIs read as normal by both groups who still
had HS on pathology. These ﬁndings suggest there is room for
improvement. The minor differences in interpretation of MRI may
improve with better imaging sequences and with improved
resolution which both may better highlight mesiotemporal
pathology and decrease variability, but this study ﬁnds that
variability in clinical interpretation of imaging studies is not a
major contributor to surgical failure. The MR techniques and ﬁeld
strength had some variation over time as any clinical study of this
length would encounter it still draws attention to need to continue
to improve imaging techniques, and such advances as quantitative
hippocampal subﬁeld changes or next generation diffusion weight
imaging could be useful [6,8]. These techniques may have help
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study suggest that inter-rater agreement on visual assessment of
MRI and FDG-PET in a clinical setting is reasonable, but continuing
innovation for imaging techniques for temporal lobe epilepsy is
warranted.
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